BioCentury | Jun 19, 2020
Management Tracks

Dubovsky succeeds Fries as Novavax CMO; plus Carl June to head Ziopharm SAB, Dewpoint, FerGene, Cambrex, Adverum, Epsilen and more

...was VP and general manager of the Asia-Pacific region at North American Science Associates Inc. Mundipharma International Ltd....
...Staff Novavax Inc. Ziopharm Oncology Inc. Dewpoint Therapeutics FerGene Inc. Adverum Biotechnologies Inc. Epsilen Bio s.r.l. Kaleido Biosciences Inc. Laboratory for Advanced Medicine Inc. Mundipharma International Ltd. MacroGenics...
BioCentury | Jan 29, 2020
Company News

Jan. 28 Company Quick Takes: Kite, Alkermes, Regeneron-Sanofi, Incyte, NantHealth-NantOmics, Sorrento, MicroCures, Paion-Mundipharma

...USAISR). MicroCures’ technology is based on foundational research from Albert Einstein College of Medicine. Paion, Mundipharma...
...in general anesthesia, the first approval for the product worldwide, according to a company spokesperson. Mundipharma International Ltd....
BioCentury | Nov 18, 2019
Company News

Biofourmis’ digital solution set for biopharmas

...predictive rather than reactive.” Biofourmis has similar partnerships with other biopharma companies, including Dublin, Ireland-based Mundipharma International Ltd....
BioCentury | Sep 16, 2019
Company News

Sept. 16 Company Quick Takes: FDA accepts Seattle Genetics' BLA; plus Akynzeo, Purdue, Amplyx, Abbott-Sanofi

...formulation of Akynzeo netupitant/palonosetron from Mundipharma China Pharmaceutical (Beijing, China) for chemotherapy-induced nausea and vomiting. Mundipharma...
...Helsinn Healthcare S.A. (Lugano, Switzerland), which holds international development rights, will supply the drug to Mundipharma...
BioCentury | Sep 11, 2019
Company News

Sept. 11 Company Quick Takes: Glaxo to buy Sitari; plus Aimmune, Xeris, Puma and United Therapeutics

...owners, the Sackler family, financed in part by the sale of a second Sackler company, Mundipharma International Ltd....
BioCentury | Sep 3, 2019
Company News

Sept. 3 Company Quick Takes: Mundipharma-Cidara, Roche-Spark, Vascepa

...Mundipharma licenses rights to Cidara’s rezafungin Cidara Therapeutics Inc. (NASDAQ:CDTX) granted Mundipharma International Ltd. (Dublin, Ireland) exclusive rights...
...to treat and prevent invasive fungal infections. Cidara will receive $30 million up front and Mundipharma...
...Staff rezafungin (CD101 IV, biafungin, sp 3025) Vascepa (amr101, icosapent ethyl, miraxion, AMR-101, LAX-101) Amarin Corp. plc Cidara Therapeutics Inc. Mundipharma International Ltd. Roche Spark...
BioCentury | Jul 10, 2019
Company News

Management tracks: Maze, Tiaki, NED, Annexon and more

...NASDAQ:OCUL) hired Patricia Kitchen as COO. She was global director of technical operations, ex-U.S. at Mundipharma International Ltd....
BioCentury | Jul 2, 2019
Company News

Management tracks: Purdue hires CSO; plus Intra-Cellular, Dementia Discovery Fund and Oasmia

...Julie Ducharme as VP and CSO. She was managing director and head of R&D at Mundipharma...
BioCentury | May 21, 2019
Financial News

Sequoia leads digital therapeutics company Biofourmis' $35M round

...as a digital pill. Rajput said the company has partnerships with Novartis AG (NYSE:NVS; SIX:NOVN), Mundipharma International Ltd....
BioCentury | Apr 4, 2019
Clinical News

Kolon TissueGene tumbles on mislabeling revelation for cell therapy Invossa

...36% drop since Monday. Hongjiang Li, Staff Writer Invossa, TissueGene-C (invossa-k inj., tg-c) Kolon Life Science Inc. Kolon TissueGene Inc. Mundipharma International Ltd. Transforming...
Items per page:
1 - 10 of 354
BioCentury | Jun 19, 2020
Management Tracks

Dubovsky succeeds Fries as Novavax CMO; plus Carl June to head Ziopharm SAB, Dewpoint, FerGene, Cambrex, Adverum, Epsilen and more

...was VP and general manager of the Asia-Pacific region at North American Science Associates Inc. Mundipharma International Ltd....
...Staff Novavax Inc. Ziopharm Oncology Inc. Dewpoint Therapeutics FerGene Inc. Adverum Biotechnologies Inc. Epsilen Bio s.r.l. Kaleido Biosciences Inc. Laboratory for Advanced Medicine Inc. Mundipharma International Ltd. MacroGenics...
BioCentury | Jan 29, 2020
Company News

Jan. 28 Company Quick Takes: Kite, Alkermes, Regeneron-Sanofi, Incyte, NantHealth-NantOmics, Sorrento, MicroCures, Paion-Mundipharma

...USAISR). MicroCures’ technology is based on foundational research from Albert Einstein College of Medicine. Paion, Mundipharma...
...in general anesthesia, the first approval for the product worldwide, according to a company spokesperson. Mundipharma International Ltd....
BioCentury | Nov 18, 2019
Company News

Biofourmis’ digital solution set for biopharmas

...predictive rather than reactive.” Biofourmis has similar partnerships with other biopharma companies, including Dublin, Ireland-based Mundipharma International Ltd....
BioCentury | Sep 16, 2019
Company News

Sept. 16 Company Quick Takes: FDA accepts Seattle Genetics' BLA; plus Akynzeo, Purdue, Amplyx, Abbott-Sanofi

...formulation of Akynzeo netupitant/palonosetron from Mundipharma China Pharmaceutical (Beijing, China) for chemotherapy-induced nausea and vomiting. Mundipharma...
...Helsinn Healthcare S.A. (Lugano, Switzerland), which holds international development rights, will supply the drug to Mundipharma...
BioCentury | Sep 11, 2019
Company News

Sept. 11 Company Quick Takes: Glaxo to buy Sitari; plus Aimmune, Xeris, Puma and United Therapeutics

...owners, the Sackler family, financed in part by the sale of a second Sackler company, Mundipharma International Ltd....
BioCentury | Sep 3, 2019
Company News

Sept. 3 Company Quick Takes: Mundipharma-Cidara, Roche-Spark, Vascepa

...Mundipharma licenses rights to Cidara’s rezafungin Cidara Therapeutics Inc. (NASDAQ:CDTX) granted Mundipharma International Ltd. (Dublin, Ireland) exclusive rights...
...to treat and prevent invasive fungal infections. Cidara will receive $30 million up front and Mundipharma...
...Staff rezafungin (CD101 IV, biafungin, sp 3025) Vascepa (amr101, icosapent ethyl, miraxion, AMR-101, LAX-101) Amarin Corp. plc Cidara Therapeutics Inc. Mundipharma International Ltd. Roche Spark...
BioCentury | Jul 10, 2019
Company News

Management tracks: Maze, Tiaki, NED, Annexon and more

...NASDAQ:OCUL) hired Patricia Kitchen as COO. She was global director of technical operations, ex-U.S. at Mundipharma International Ltd....
BioCentury | Jul 2, 2019
Company News

Management tracks: Purdue hires CSO; plus Intra-Cellular, Dementia Discovery Fund and Oasmia

...Julie Ducharme as VP and CSO. She was managing director and head of R&D at Mundipharma...
BioCentury | May 21, 2019
Financial News

Sequoia leads digital therapeutics company Biofourmis' $35M round

...as a digital pill. Rajput said the company has partnerships with Novartis AG (NYSE:NVS; SIX:NOVN), Mundipharma International Ltd....
BioCentury | Apr 4, 2019
Clinical News

Kolon TissueGene tumbles on mislabeling revelation for cell therapy Invossa

...36% drop since Monday. Hongjiang Li, Staff Writer Invossa, TissueGene-C (invossa-k inj., tg-c) Kolon Life Science Inc. Kolon TissueGene Inc. Mundipharma International Ltd. Transforming...
Items per page:
1 - 10 of 354